A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Clinical trial NCT05721937 · RECRUITING

Trial details

NCT number: NCT05721937
Sponsor: Pfizer
Status: RECRUITING
Study type: OBSERVATIONAL

Atopic Dermatitis

Start date: 2023-07-25
Primary completion: 2027-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.